25 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/25/2903595/0/en/Eckert-Ziegler-Subsidiary-Pentixapharm-Receives-Encouraging-FDA-Feedback-to-Initiate-Phase-III-Trial-with-PentixaFor-as-Radiopharmaceutical-Diagnostic-in-Primary-Aldosteronism.html
LOOKING FOR A SUPPLIER?